These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32464321)

  • 1. Counterfactual clinical prediction models could help to infer individualized treatment effects in randomized controlled trials-An illustration with the International Stroke Trial.
    Nguyen TL; Collins GS; Landais P; Le Manach Y
    J Clin Epidemiol; 2020 Sep; 125():47-56. PubMed ID: 32464321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design.
    Chalos V; A van de Graaf R; Roozenbeek B; C G M van Es A; M den Hertog H; Staals J; van Dijk L; F M Jenniskens S; J van Oostenbrugge R; H van Zwam W; B W E M Roos Y; B L M Majoie C; F Lingsma H; van der Lugt A; W J Dippel D;
    Trials; 2020 Jul; 21(1):644. PubMed ID: 32665035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
    Chen ZM; Sandercock P; Pan HC; Counsell C; Collins R; Liu LS; Xie JX; Warlow C; Peto R
    Stroke; 2000 Jun; 31(6):1240-9. PubMed ID: 10835439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials.
    Thompson DD; Murray GD; Candelise L; Chen Z; Sandercock PA; Whiteley WN
    Int J Stroke; 2015 Oct; 10(7):1024-30. PubMed ID: 25864571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
    Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial.
    Chen Y; Liu Y; Zhang J; Zhou K; Zhang X; Dai H; Yang B; Shang H
    Trials; 2022 Apr; 23(1):285. PubMed ID: 35410433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
    JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study.
    Hou X; Li X; Wang X; Chen H
    Stroke Vasc Neurol; 2018 Dec; 3(4):263-267. PubMed ID: 30637134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
    Johnston SC; Amarenco P; Aunes M; Denison H; Evans SR; Himmelmann A; Jahreskog M; James S; Knutsson M; Ladenvall P; Molina CA; Nylander S; Röther J; Wang Y;
    Stroke; 2021 Nov; 52(11):3482-3489. PubMed ID: 34477459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
    JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin or heparin in acute stroke.
    Pereira AC; Brown MM
    Br Med Bull; 2000; 56(2):413-21. PubMed ID: 11092090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
    Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
    JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.
    Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y; Johnston SC;
    Stroke; 2020 Dec; 51(12):3504-3513. PubMed ID: 33198608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry.
    Lee HL; Kim JT; Lee JS; Park MS; Choi KH; Cho KH; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Sun Oh M; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Lee J; Bae HJ
    Circ Cardiovasc Qual Outcomes; 2020 Nov; 13(11):e006474. PubMed ID: 33201737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study.
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):371-6. PubMed ID: 8774398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.
    Wang Y; Pan Y; Li H; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Birve F; Ladenvall P; Molina CA; Johnston SC;
    JAMA Neurol; 2021 Sep; 78(9):1091-1098. PubMed ID: 34244703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial).
    Zapata-Arriaza E; Medina-Rodríguez M; Moniche Álvarez F; de Albóniga-Chindurza A; Aguilar-Pérez M; Ainz-Gómez L; Baena-Palomino P; Zamora A; Pardo-Galiana B; Delgado-Acosta F; Valverde Moyano R; Jiménez-Gómez E; Bravo Rey I; Oteros Fernández R; Escudero-Martínez I; Vielba-Gomez I; Morales Caba L; Díaz Pérez J; García Molina E; Mosteiro S; Castellanos Rodrigo MDM; Amaya Pascasio L; Hidalgo C; Freijo Guerrero MDM; González Díaz E; Ramírez Moreno JM; Fernández Prudencio L; Terceño Izaga M; Bashir Viturro S; Gamero-García MÁ; Jiménez Jorge S; Rosso Fernández C; Montaner J; González García A
    Trials; 2024 Jan; 25(1):35. PubMed ID: 38195586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.